StemSynergy Therapeutics®
"Innovative Stem Cell Research. Targeted Cancer Therapeutics."


SSTI is focused on the discovery and development of novel drugs that target molecules and cellular processes fundamental to cancer. Our drug targets include those in the Wnt, Notch, and Myc signaling pathways. We have already identified potent modulators of these pathways, and have patent protection on multiple lead compounds. These breakthrough technologies include:

Wnt Inhibitor Program

Notch Inhibitor Program

Familial Adenomatous Polyposis (FAP) Program

Scientific Team

SSTI has a multidisciplinary team of scientists.

Meet the Team


Meet the founders behind StemSynergy Therapeutics, Inc.



SSTI targets cancer stem cell pathways that drive tumor growth.

Scientific Programs